| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.943343 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250108100941 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240918e202412 onc ob f000 0 eng d |
|---|
| 020 | |a9780660736907 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-299/2024E-PDF |
|---|
| 245 | 00|aGuidance document : |bproduct monograph. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cDecember 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (iii, 69 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : monographie de produit. |
|---|
| 500 | |a"Date Adopted 2024-08-30. Effective Date 2024-12-23." |
|---|
| 500 | |a"Pub.: 240541." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 650 | 0|aDrugs|xSpecifications|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.943344 |
|---|
| 795 | |tGuidance document : |w(CaOODSP)9.890868 |
|---|
| 856 | 40|qPDF|s757 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-299-2024-eng.pdf |
|---|